Drugs / IN-C004
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04654078 | Jan → Feb 2021 | — | HK inno.N Corporation | Completed | No outcome recorded |
| Phase 1 | NCT04654065 | Jan 2021 | — | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IN-C004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04654078 ↗ |
| Route | Oral | “One time dose of IN-C004 taken orally.” NCT04654065 ↗ |